Biotech

All Articles

Vaccine and also Keytruda combination successful in squamous cell cancer

.Invulnerable gate inhibitors are the superheroes of cancer therapy. Medicines like Bristol Myers Sq...

Cue Biopharma queues up J&ampJ veterinarian as CBO-- Chutes &amp Ladders

.Invite to recently's Chutes &amp Ladders, our roundup of substantial management hirings, shootings ...

Regeneron's Opdualag opponent presents 57% response cost

.Regeneron is actually back along with long-lasting consequence for its own LAG-3 inhibitor and PD-1...

AstraZeneca posts data on in-house competitors to AbbVie, Pfizer ADCs

.AstraZeneca has discussed an early check out the performance of its own internal antibody-drug conj...

iTeos- GSK's TIGIT superstar reveals significant remodeling

.After introducing a stage 3 launch based on positive midstage results, iTeos and also GSK are lastl...

More collective FDA can easily accelerate rare condition R&ampD: file

.The FDA ought to be a lot more available as well as joint to release a surge in commendations of un...

Zenas, MBX, Bicara scalp to Nasdaq in warm time for biotech IPOs

.It is actually an extraordinarily busy Friday for biotech IPOs, along with Zenas BioPharma, MBX and...

Atea's COVID antiviral neglects to halt hospitalizations in stage 3

.Atea Pharmaceuticals' antiviral has neglected one more COVID-19 test, but the biotech still holds o...

Neurocrine's proposal to conserve mental illness possibility falls short

.Neurocrine Biosciences' schizophrenia plan pivot has actually failed. The biotech was not able to d...

Sanofi spends $110M upfront for late-stage radioligand therapy

.Sanofi has brought in a late entrance to the radioligand party, paying 100 million europeans ($ 110...